Acute severe asthma: Part 2. Current therapy
Garmon, R.G.; Zemenick, R.B.
Journal of the American Osteopathic Association 92(3): 343-4 347-52
1992
ISSN/ISBN: 0098-6151 PMID: 1592659 Document Number: 400899
Acute severe asthma is an extremely common and serious public health problem in the United States. Current optimum therapy of acute severe asthma includes supplemental oxygenation, nebulized .beta.-adrenergic receptor agonist therapy, and prompt use of glucocorticosteroids. In view of its low therapeutic index and the availability of more effective, less toxic agents, theophylline is no longer considered a first-line treatment. Ipratropium bromide combined with .beta.-agonist may augment bronchodilator responsiveness.